Nivolumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4)

Eun-Kee Song

Nivolumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4)

Eun-Kee Song

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Original language	Korean
Journal	Cancer Research and Treatment
State	Published - 2025.07.2

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{ac86c93d16494fdfb8122e8e6ddd62b6,

title = "Nivolumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4)",

author = "Eun-Kee Song",

year = "2025",

month = jul,

day = "2",

language = "Korean",

journal = "Cancer Research and Treatment",

issn = "1598-2998",

}

Nivolumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4). / Song, Eun-Kee.
In: Cancer Research and Treatment, 02.07.2025.

Research output: Contribution to journal › Journal article › peer-review

TY - JOUR

T1 - Nivolumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4)

AU - Song, Eun-Kee

PY - 2025/7/2

Y1 - 2025/7/2

M3 - Journal article

SN - 1598-2998

JO - Cancer Research and Treatment

JF - Cancer Research and Treatment

ER -